Company profile for Forte Biosciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ForteBio is a business unit of Molecular Devices LLC based in Fremont, CA. We offer solutions for biomolecular analysis, including real-time analysis of biomolecular interactions (protein quantification and characterization of protein-protein interactions, etc.) in micro-volume sample sizes, providing information on affinity, kinetics, and concentration. Our products include instrumentation, software, biosensors, and supportin...
ForteBio is a business unit of Molecular Devices LLC based in Fremont, CA. We offer solutions for biomolecular analysis, including real-time analysis of biomolecular interactions (protein quantification and characterization of protein-protein interactions, etc.) in micro-volume sample sizes, providing information on affinity, kinetics, and concentration. Our products include instrumentation, software, biosensors, and supporting services. Our customers perform crucial work in life sciences research across academic, government and industrial settings, including pharmaceutical research, development and manufacturing.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
47661 Fremont Boulevard Fremont, CA 94538
Telephone
Telephone
888.OCTET-75
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251222851400/en/Forte-Biosciences-Inc.-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rules

BUSINESSWIRE
22 Dec 2025

https://www.businesswire.com/news/home/20251124307887/en/Forte-Biosciences-Inc.-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rules

BUSINESSWIRE
24 Nov 2025

https://www.businesswire.com/news/home/20251114817278/en/Forte-Biosciences-Inc.-Announces-Third-Quarter-2025-Results-and-Provides-Update

BUSINESSWIRE
14 Nov 2025

https://www.businesswire.com/news/home/20251103872383/en/Forte-Biosciences-Inc.-to-Present-at-Upcoming-Healthcare-Conferences

BUSINESSWIRE
03 Nov 2025

https://www.businesswire.com/news/home/20251003067466/en/Forte-Biosciences-Inc.-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rules

BUSINESSWIRE
03 Oct 2025

https://www.businesswire.com/news/home/20250915660032/en/Forte-Biosciences-Inc.-Announces-Presentation-of-FB102-Celiac-Disease-Trial-at-Tampere-Celiac-Disease-Symposium

BUSINESSWIRE
15 Sep 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty